Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Sangamo Therapeutics Inc (NASDAQ: SGMO) was $0.92 for the day, down -9.75% from the previous closing price of $1.02. In other words, the price has decreased by -$9.75 from its previous closing price. On the day, 3.9 million shares were traded.
Ratios:
Our analysis of SGMO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.
On December 10, 2024, H.C. Wainwright reiterated its Buy ratingand also kept the price unchanged to $10.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 03, 2023, whereas the target price for the stock was revised from $6 to $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.67 while its Price-to-Book (P/B) ratio in mrq is 4.91.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -33.23%, while the 200-Day Moving Average is calculated to be -18.81%.
Shares Statistics:
A total of 208.62M shares are outstanding, with a floating share count of 199.25M. Insiders hold about 4.50% of the company’s shares, while institutions hold 29.74% stake in the company.
